Literature DB >> 2502675

Evidence for inhibition of exodus of small neutral amino acids from non-brain tissues in hyperphenylalaninaemic rats.

C de Cespedes1, J G Thoene, K Lowler, H N Christensen.   

Abstract

The mechanism of the depletion of several plasma amino acids in PKU has remained unexplained. In the present study, a statistically significant decrease in the plasma concentration of several amino acids was observed 2 h after the intraperitoneal injection of Phe to weanling rats. The pattern was very similar to the one observed in PKU patients. Statistically significant increases in the distribution ratios liver/plasma and, mainly, muscle/plasma ratios accompanied in most of the cases the corresponding decreases in plasma concentrations. Equimolar injection under the same conditions of the non-insulinogenic transport system L analogue, the a(+/-) isomer of the 2-aminonorbornane-2-carboxylic acid, produced, in a parallel effect to Phe, statistically significant increases in the distribution ratios of Ala and Gly, and probably of Pro in muscle, as well as of Ala in liver. These results seem to indicate that the high intracellular Phe attained inhibits the exodus of small neutral amino acids through system L, causing their depletion in plasma and ultimately in the brain. This effect may be additive to the inhibition by Phe of the entry of bulky neutral amino acids at the level of the blood-brain barrier. Further study is needed to assess the relevance of these effects to PKU.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2502675     DOI: 10.1007/bf01800722

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  35 in total

1.  Synthetic amino acids and the nature of L-DOPA transport at the blood-brain barrier.

Authors:  L A Wade; R Katzman
Journal:  J Neurochem       Date:  1975-12       Impact factor: 5.372

2.  Effects of feeding individual amino acids upon the distribution of other amino acids between cells and extracellular fluid.

Authors:  H N CHRISTENSEN; J A STREICHER; R L ELBINGER
Journal:  J Biol Chem       Date:  1948-02       Impact factor: 5.157

3.  Where do the depleted plasma amino acids go in phenylketonuria?

Authors:  H N Christensen
Journal:  Biochem J       Date:  1986-06-15       Impact factor: 3.857

4.  The effects of high phenylalanine concentrations on serotonin and catecholamine metabolism in the human brain.

Authors:  C M McKean
Journal:  Brain Res       Date:  1972-12-12       Impact factor: 3.252

5.  Transport of metabolic substrates through the blood-brain barrier.

Authors:  W M Pardridge; W H Oldendorf
Journal:  J Neurochem       Date:  1977-01       Impact factor: 5.372

6.  Plasma and cerebrospinal fluid amino acid concentrations in phenylketonuria during the newborn period.

Authors:  S E Snyderman; C Sansaricq; P M Norton; J V Castro
Journal:  J Pediatr       Date:  1981-07       Impact factor: 4.406

Review 7.  Interorgan amino acid nutrition.

Authors:  H N Christensen
Journal:  Physiol Rev       Date:  1982-10       Impact factor: 37.312

8.  Disturbances of amino acid transport in rats with experimental hyperphenylalaninaemia.

Authors:  T Zanić-Grubisić; K Lipovac
Journal:  J Inherit Metab Dis       Date:  1981       Impact factor: 4.982

9.  Intensified gradients for endogenous amino acid substrates for transport system L on injecting a specific competitor for that system.

Authors:  H N Christensen; A M Cullen
Journal:  Life Sci       Date:  1981-08-17       Impact factor: 5.037

Review 10.  Progress in experimental phenylketonuria: a critical review.

Authors:  C V Vorhees; R E Butcher; H K Berry
Journal:  Neurosci Biobehav Rev       Date:  1981       Impact factor: 8.989

View more
  3 in total

1.  Leucine and tissue distribution of bulky and small neutral amino acids in rats: dissociation between transport and insulin-mediated effects.

Authors:  C de Céspedes; J G Thoene; K Lowler; H N Christensen
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

2.  Reduction of large neutral amino acid concentrations in plasma and CSF of patients with maple syrup urine disease during crises.

Authors:  M Wajner; D M Coelho; A G Barschak; P R Araújo; R F Pires; F L Lulhier; C R Vargas
Journal:  J Inherit Metab Dis       Date:  2000-07       Impact factor: 4.982

3.  Alanine prevents the reduction of pyruvate kinase activity in brain cortex of rats subjected to chemically induced hyperphenylalaninemia.

Authors:  Luciane Rosa Feksa; Andrea Renata Cornelio; Virginia Cielo Rech; Carlos Severo Dutra-Filho; Angela Terezinha Souza Wyse; Moacir Wajner; Clóvis Milton Duval Wannmacher
Journal:  Neurochem Res       Date:  2002-09       Impact factor: 3.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.